Exklusiver Live-Stream direkt von der World of Trading - 2 Tage mit einzigartigen Themen und Experten. Kostenlos teilnehmen + Videos erhalten. -w-
14.11.2017 16:54:00

Evolent Health to Participate in Upcoming Investor Conference

WASHINGTON, Nov. 14, 2017 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH) ("Evolent"), a company providing an integrated value-based care platform to the nation's leading health systems and physician organizations, today announced that Chief Executive Officer and Co-Founder Frank Williams and Chief Financial Officer Nicky McGrane will participate in an upcoming investor conference.

  • Mr. Williams and Mr. McGrane will present at the 29th Annual Piper Jaffray Healthcare Conference in New York on Tuesday, November 28, 2017 at 3:30 p.m. EST. A live audio-only webcast and related presentation materials will be available on the investor relations section of Evolent's website at http://ir.evolenthealth.com/.

Evolent Health Logo

About Evolent Health
Evolent Health partners with leading provider organizations to achieve superior clinical and financial results in value-based care. With a provider heritage and over 20 years of health plan administration experience, Evolent operates in more than 30 U.S. health care markets, actively managing care across Medicare, Medicaid, commercial and self-funded adult and pediatric populations. With the experience to drive change, Evolent confidently stands by a commitment to achieve results. For more information, visit evolenthealth.com.

View original content with multimedia:http://www.prnewswire.com/news-releases/evolent-health-to-participate-in-upcoming-investor-conference-300555642.html

SOURCE Evolent Health

Analysen zu Evolent Health Inc (A)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Evolent Health Inc (A) 10,80 -0,92% Evolent Health Inc (A)